Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Bron

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
Stem Cell Reviews and Reports|September 18, 2012
Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory primingMehdi Najar, Gordana Raicevic, Hussein Fayyad-Kazan, et al.
Patient Preference and Adherence|September 30, 2024
Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World DataSandra Michiels, Sandra Tricas-Sauras, Adriano Salaroli, et al.
Stem Cells and Development|June 19, 2015
Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose TissueHélène Busser, Mehdi Najar, Gordana Raicevic, et al.
Cytotherapy|June 25, 2009
In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissuesTatiana Tondreau, Nathalie Meuleman, Basile Stamatopoulos, et al.
Experimental Hematology|June 24, 2010
Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functionsMehdi Najar, Gordana Raicevic, Hicham Id Boufker, et al.
Epigenetics|December 2, 2014
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patientsMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Molecular Medicine (Cambridge, Mass.)|January 14, 2015
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaBasile Stamatopoulos, Michaël Van Damme, Emerence Crompot, et al.
Tissue Engineering. Part A|July 6, 2010
Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factorMehdi Najar, Gordana Raicevic, Hicham Id Boufker, et al.
Cytotherapy|July 1, 2009
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6Mehdi Najar, Redouane Rouas, Gordana Raicevic, et al.
Annals of Hematology|September 28, 2015
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)Theo de Witte, Stefan Suciu, Liv Meert, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Stem Cell Reviews and Reports|September 18, 2012
Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory primingMehdi Najar, Gordana Raicevic, Hussein Fayyad-Kazan, et al.
Patient Preference and Adherence|September 30, 2024
Imatinib Adherence and Persistence in Patients with Chronic Myeloid Leukemia in Belgium: Evidence from Real-World DataSandra Michiels, Sandra Tricas-Sauras, Adriano Salaroli, et al.
Stem Cells and Development|June 19, 2015
Isolation and Characterization of Human Mesenchymal Stromal Cell Subpopulations: Comparison of Bone Marrow and Adipose TissueHélène Busser, Mehdi Najar, Gordana Raicevic, et al.
Cytotherapy|June 25, 2009
In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissuesTatiana Tondreau, Nathalie Meuleman, Basile Stamatopoulos, et al.
Experimental Hematology|June 24, 2010
Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functionsMehdi Najar, Gordana Raicevic, Hicham Id Boufker, et al.
Epigenetics|December 2, 2014
Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patientsMichaël Van Damme, Emerence Crompot, Nathalie Meuleman, et al.
Molecular Medicine (Cambridge, Mass.)|January 14, 2015
Opposite Prognostic Significance of Cellular and Serum Circulating MicroRNA-150 in Patients with Chronic Lymphocytic LeukemiaBasile Stamatopoulos, Michaël Van Damme, Emerence Crompot, et al.
Tissue Engineering. Part A|July 6, 2010
Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factorMehdi Najar, Gordana Raicevic, Hicham Id Boufker, et al.
Cytotherapy|July 1, 2009
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6Mehdi Najar, Redouane Rouas, Gordana Raicevic, et al.
Annals of Hematology|September 28, 2015
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)Theo de Witte, Stefan Suciu, Liv Meert, et al.
Pageof 17